Table 3.
Previous cardiac conditions.
| Series | Type of valve | COPD | CAD | h/o MI | h/o CABG | h/o PCI |
|---|---|---|---|---|---|---|
| Makkar et al. [42] | Sapien | 74 (41%) | 121 (68%) | 33 (18%) | 58 (32%) | 47 (26%) |
| Kodali et al. [14] | Sapien | 151 (43%) | 260 (75%) | 92 (26%) | 147 (42%) | 116 (33%) |
| Thomas et al. [12, 13] | Sapien | 220 (48%) | 10 (2%) | 81 (17%) | ||
| Thomas et al. [12, 13] | Sapien | 317 (55%) | 10 (2%) | 155 (27%) | ||
| Himbert et al. [10] (TF) | Sapien | 14 (27%) | 25 (49%) | 4 (8%) | 11 (22%) | 7 (20%) |
| Himbert et al. [10] (TA) | Sapien | 6 (26%) | 20 (87%) | 11 (48%) | 12 (52%) | 4 (27%) |
| Grube et al. [9] | CoreValve | 81 (60%) | 35 (26%) | 41 (30%) | ||
| Litzler et al. [15] | Sapien | 22 (36%) | 21 (34%) | 23 (38%) | ||
| Tamburino et al. [16] | CoreValve | 141 (21%) | 320 (48%) | 143 (22%) | 104 (16%) | 189 (29%) |
| Avanzas et al. [17] | CoreValve | 36 (33%) | 9 (8%) | 15 (14%) | ||
| Kempfert et al. [11] | Sapien | 129 (43%) | 159 (53%) | 8 (3%) | ||
| Gotzmann et al. [18] | CoreValve | |||||
| Bleiziffer et al. [19] | Sapien and CoreValve | 52 (23%) | 118 (52%) |